Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-7 ERVK-10 DDI1 ERVK-8 ERVK-18 ERVK-25	9.11e-09	37	148	7	GO:0004190
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	9.32e-09	11	148	5	GO:0004523
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-7 ERVK-10 DDI1 ERVK-8 ERVK-18 ERVK-25	1.11e-08	38	148	7	GO:0070001
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	3.97e-08	14	148	5	GO:0003964
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	3.87e-07	21	148	5	GO:0035613
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	7.53e-06	37	148	5	GO:0016891
GeneOntologyMolecularFunction	RNA nuclease activity	ERVK-6 ERVK-7 ERVK-10 RNASE13 PNPT1 ERVK-8 MARF1 ERVK-11	7.97e-06	136	148	8	GO:0004540
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	8.61e-06	38	148	5	GO:0034061
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	2.24e-05	46	148	5	GO:0016893
GeneOntologyMolecularFunction	peptidase activity	USP17L7 CLPP ERVK-6 USP17L4 USP17L2 USP17L1 ERVK-7 ERVK-10 DDI1 AGBL4 ERVK-8 ERVK-18 USP17L3 ADAMTS20 ERVK-25 USP17L8	2.90e-05	654	148	16	GO:0008233
GeneOntologyMolecularFunction	phosphorylation-dependent protein binding	ANK2 ANK3 TOPBP1	4.61e-05	10	148	3	GO:0140031
GeneOntologyMolecularFunction	interleukin-1, type I, activating receptor activity	IL1RL2 IL1R1	5.46e-05	2	148	2	GO:0004909
GeneOntologyMolecularFunction	microfilament motor activity	MYO1G MYO9B MYH7B MYO3A	1.76e-04	38	148	4	GO:0000146
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.07e-04	114	148	6	GO:0004843
GeneOntologyMolecularFunction	chloride ion binding	NLGN4Y SLC22A6 NLGN4X	2.08e-04	16	148	3	GO:0031404
GeneOntologyMolecularFunction	RNA endonuclease activity	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	3.03e-04	79	148	5	GO:0004521
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.26e-04	124	148	6	GO:0101005
GeneOntologyMolecularFunction	nuclease activity	ERVK-6 ERVK-7 ERVK-10 RNASE13 PNPT1 ERVK-8 MARF1 ERVK-11	3.34e-04	231	148	8	GO:0004518
GeneOntologyMolecularFunction	inositol 1,3,4,5 tetrakisphosphate binding	SYT2 ITPR3	5.38e-04	5	148	2	GO:0043533
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	5.55e-04	137	148	6	GO:0019783
GeneOntologyMolecularFunction	RNA polymerase III type 3 promoter sequence-specific DNA binding	MTOR SNAPC3	8.03e-04	6	148	2	GO:0001006
GeneOntologyMolecularFunction	nucleotidyltransferase activity	ERVK-6 ERVK-7 ERVK-10 PNPT1 ERVK-8 ERVK-11	9.56e-04	152	148	6	GO:0016779
GeneOntologyMolecularFunction	RNA polymerase III cis-regulatory region sequence-specific DNA binding	MTOR SNAPC3	1.12e-03	7	148	2	GO:0000992
GeneOntologyMolecularFunction	RNA polymerase III transcription regulatory region sequence-specific DNA binding	MTOR SNAPC3	1.48e-03	8	148	2	GO:0001016
GeneOntologyMolecularFunction	interleukin-1 receptor activity	IL1RL2 IL1R1	1.48e-03	8	148	2	GO:0004908
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO1G MYL3 MYO9B MYH7B MYO3A	1.87e-03	118	148	5	GO:0003774
GeneOntologyMolecularFunction	spectrin binding	ANK2 ANK3 GBP2	2.02e-03	34	148	3	GO:0030507
GeneOntologyBiologicalProcess	DNA integration	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	2.26e-08	13	149	5	GO:0015074
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-11	2.45e-05	48	149	5	GO:0000731
GeneOntologyBiologicalProcess	DNA-templated DNA replication	ERVK-6 TOPBP1 GINS4 ERVK-7 ERVK-10 ORC1 ERVK-8 ERVK-11	4.65e-05	178	149	8	GO:0006261
GeneOntologyCellularComponent	myosin complex	MYO1G MYL3 MYO9B MYH7B MYO3A	6.12e-05	59	148	5	GO:0016459
Domain	Ank	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 TNNI3K KANK1 ANKRD34B ANKRD12	1.38e-06	228	142	11	PF00023
Domain	ANK	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 TNNI3K KANK1 ANKRD34B ANKRD12	3.51e-06	251	142	11	SM00248
Domain	ANK_REPEAT	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 TNNI3K KANK1 ANKRD34B ANKRD12	3.79e-06	253	142	11	PS50088
Domain	Ankyrin_rpt-contain_dom	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 TNNI3K KANK1 ANKRD34B ANKRD12	3.94e-06	254	142	11	IPR020683
Domain	ANK_REP_REGION	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 TNNI3K KANK1 ANKRD34B ANKRD12	3.94e-06	254	142	11	PS50297
Domain	Ankyrin_rpt	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 TNNI3K KANK1 ANKRD34B ANKRD12	5.29e-06	262	142	11	IPR002110
Domain	Ank_2	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 KANK1 ANKRD34B ANKRD12	5.87e-06	215	142	10	PF12796
Domain	UCH	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.66e-05	71	142	6	PF00443
Domain	USP_2	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.66e-05	71	142	6	PS00973
Domain	USP_3	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.80e-05	72	142	6	PS50235
Domain	USP_dom	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.80e-05	72	142	6	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.80e-05	72	142	6	IPR001394
Domain	-	TANC2 ANKRD31 ANK2 ANK3 BCORL1 LRRK1 ANKRD50 KANK1 ANKRD34B ANKRD12	2.04e-05	248	142	10	1.25.40.20
Domain	IL-1_rcpt_I-typ	IL1RL2 IL1R1	5.74e-05	2	142	2	IPR004076
Domain	NLGN4	NLGN4Y NLGN4X	5.74e-05	2	142	2	IPR030025
Domain	USP_CS	USP17L7 USP17L2 USP17L1 USP17L3 USP17L8	1.46e-04	66	142	5	IPR018200
Domain	USP_1	USP17L7 USP17L4 USP17L2 USP17L3 USP17L8	1.93e-04	70	142	5	PS00972
Domain	Myosin_head_motor_dom	MYO1G MYO9B MYH7B MYO3A	1.93e-04	38	142	4	IPR001609
Domain	MYOSIN_MOTOR	MYO1G MYO9B MYH7B MYO3A	1.93e-04	38	142	4	PS51456
Domain	Myosin_head	MYO1G MYO9B MYH7B MYO3A	1.93e-04	38	142	4	PF00063
Domain	MYSc	MYO1G MYO9B MYH7B MYO3A	1.93e-04	38	142	4	SM00242
Domain	HABP4_PAI-RBP1	USP17L7 USP17L2 USP17L3	2.24e-04	16	142	3	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L2 USP17L3	2.24e-04	16	142	3	IPR006861
Domain	PRAME_family	PRAMEF25 PRAMEF15 PRAMEF27	3.81e-04	19	142	3	IPR026271
Domain	Nlgn	NLGN4Y NLGN4X	5.65e-04	5	142	2	IPR000460
Domain	IL-1_rcpt_I/II-typ	IL1RL2 IL1R1	8.44e-04	6	142	2	IPR004074
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	8.99e-07	45	104	6	MM15671
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.31e-12	10	152	6	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	5.70e-12	12	152	6	24695638
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 IL1R1 USP17L8	1.19e-11	25	152	7	21115691
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.84e-11	14	152	6	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.63e-10	19	152	6	28067227
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.24e-10	21	152	6	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.24e-10	21	152	6	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.24e-10	21	152	6	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.24e-10	21	152	6	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.24e-10	21	152	6	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	3.24e-10	21	152	6	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	4.44e-10	22	152	6	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.96e-10	24	152	6	8995226
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.35e-09	26	152	6	35816173
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L4 USP17L2 USP17L1 PRAMEF15 USP17L3 USP17L8	2.26e-09	50	152	7	31806660
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	2.76e-09	29	152	6	32527007
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	6.34e-09	33	152	6	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.67e-09	34	152	6	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	9.22e-09	35	152	6	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	9.22e-09	35	152	6	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.10e-08	36	152	6	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.31e-08	37	152	6	20228808
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-6 ERVK-7 ERVK-10 ERVK-8 ERVK-18 ERVK-25 ERVK-11	1.97e-07	94	152	7	21542922
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-6 ERVK-7 ERVK-10	3.26e-07	4	152	3	10469592
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-6 ERVK-7 ERVK-18	8.13e-07	5	152	3	12629516
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-10 ERVK-18 ERVK-25 ERVK-11	1.02e-06	18	152	4	18664271
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.56e-06	81	152	6	12838346
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L8	2.20e-06	48	152	5	16421571
Pubmed	Microglia ablation alleviates myelin-associated catatonic signs in mice.	NLGN4Y NLGN4X CADPS	6.74e-06	9	152	3	29252214
Pubmed	Polymorphisms in TSHR and IL1RN genes and the risk and prognosis of Hashimoto's thyroiditis.	TSHR IL1R1	1.90e-05	2	152	2	24328419
Pubmed	Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway.	PTPN11 MTOR	1.90e-05	2	152	2	21887223
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4Y NLGN4X	1.90e-05	2	152	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4Y NLGN4X	1.90e-05	2	152	2	24855039
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4Y NLGN4X	1.90e-05	2	152	2	37001827
Pubmed	Whole exome sequencing identifies hemizygous deletions in the UGT2B28 and USP17L2 genes in a three‑generation family with endometriosis.	USP17L2 UGT2B28	1.90e-05	2	152	2	30628680
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4Y NLGN4X	1.90e-05	2	152	2	18434543
Pubmed	The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling.	PTPN11 MTOR	1.90e-05	2	152	2	22058153
Pubmed	Revisiting ankyrin-InsP3 receptor interactions: ankyrin-B associates with the cytoplasmic N-terminus of the InsP3 receptor.	ANK2 ITPR3	1.90e-05	2	152	2	18275062
Pubmed	Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation.	MYO1G ARHGAP45	1.90e-05	2	152	2	20509834
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4Y NLGN4X	1.90e-05	2	152	2	37080762
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4Y NLGN4X	1.90e-05	2	152	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4Y NLGN4X	1.90e-05	2	152	2	26456829
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.90e-05	2	152	2	11781319
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4Y NLGN4X	1.90e-05	2	152	2	24104404
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.90e-05	2	152	2	25383926
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4Y NLGN4X	1.90e-05	2	152	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4Y NLGN4X	1.90e-05	2	152	2	22989184
Pubmed	Activity-independent targeting of mTOR to lysosomes in primary osteoclasts.	TCIRG1 MTOR	1.90e-05	2	152	2	28592812
Pubmed	Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.	ERVK-6 ERVK-18	1.90e-05	2	152	2	11672541
Pubmed	Advancing the understanding of autism disease mechanisms through genetics.	NLGN4Y NLGN4X TBR1	2.27e-05	13	152	3	27050589
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	PREX2 ITPR3 TMEM132C MARF1 HYDIN	2.76e-05	80	152	5	19389623
Pubmed	Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.	RBMS1 B4GALT6 SCN7A	4.40e-05	16	152	3	19451621
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 ANKRD31 USP17L4 USP17L2 USP17L1 PRAMEF15 PREX2 HHIP C1GALT1C1 USP17L3 TTLL13 USP17L8	4.40e-05	674	152	12	37196079
Pubmed	Regulating ankyrin dynamics: Roles of sigma-1 receptors.	ANK2 ITPR3	5.68e-05	3	152	2	11149946
Pubmed	Daam1 regulates fascin for actin assembly in mouse oocyte meiosis.	DAAM1 FSCN1	5.68e-05	3	152	2	28682694
Pubmed	Association between the DNA methylations of POMC, MC4R, and HNF4A and metabolic profiles in the blood of children aged 7-9 years.	HNF1A MC4R	5.68e-05	3	152	2	29598821
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	5.68e-05	3	152	2	15611082
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-11	5.68e-05	3	152	2	9971820
Pubmed	The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription.	TCF20 TOPBP1	5.68e-05	3	152	2	17913746
Pubmed	Transcriptional regulation of human and mouse organic anion transporter 1 by hepatocyte nuclear factor 1 alpha/beta.	HNF1A SLC22A6	5.68e-05	3	152	2	18029548
Pubmed	AFF4 regulates osteogenic potential of human periodontal ligament stem cells via mTOR-ULK1-autophagy axis.	MTOR AFF4	5.68e-05	3	152	2	37731335
Pubmed	Depletion of tumor suppressor Kank1 induces centrosomal amplification via hyperactivation of RhoA.	KANK1 DAAM1	5.68e-05	3	152	2	28284839
Pubmed	SHP-2 regulates cell growth by controlling the mTOR/S6 kinase 1 pathway.	PTPN11 MTOR	5.68e-05	3	152	2	17229738
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4Y NLGN4X	5.68e-05	3	152	2	32011705
Pubmed	Co-Localization of Insulin-Like Growth Factor Binding Protein-1, Casein Kinase-2β, and Mechanistic Target of Rapamycin in Human Hepatocellular Carcinoma Cells as Demonstrated by Dual Immunofluorescence and in Situ Proximity Ligation Assay.	MTOR CSNK2B	5.68e-05	3	152	2	29037858
Pubmed	Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.	ERVK-6 ERVK-18	5.68e-05	3	152	2	10516026
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK2 ANK3	5.68e-05	3	152	2	33410423
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4Y NLGN4X	5.68e-05	3	152	2	18628683
Pubmed	Synaptotagmin 2 couples mucin granule exocytosis to Ca2+ signaling from endoplasmic reticulum.	ANK2 SYT2	5.68e-05	3	152	2	19208631
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4Y NLGN4X	5.68e-05	3	152	2	21282647
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK2 ANK3	5.68e-05	3	152	2	34289389
Pubmed	Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology.	ITPR3 PRKRA HYDIN	1.03e-04	21	152	3	26234751
Pubmed	CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.	DOCK1 ELMO3	1.13e-04	4	152	2	11595183
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4Y NLGN4X	1.13e-04	4	152	2	12669065
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4Y NLGN4X	1.13e-04	4	152	2	22671294
Pubmed	Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.	HNF1A FSCN1	1.13e-04	4	152	2	17638895
Pubmed	Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication.	NLGN4Y NLGN4X	1.13e-04	4	152	2	20579107
Pubmed	Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization of NFATc4.	MTOR MAPK7	1.13e-04	4	152	2	18347059
Pubmed	Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.	PTPN11 MTOR	1.13e-04	4	152	2	27840422
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN4Y NLGN4X	1.13e-04	4	152	2	16077734
Pubmed	Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations.	NLGN4Y NLGN4X	1.13e-04	4	152	2	17292328
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-6 ERVK-10	1.13e-04	4	152	2	7983737
Pubmed	A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.	IL1RL2 IL1R1	1.13e-04	4	152	2	1833184
Pubmed	Generation and annotation of the DNA sequences of human chromosomes 2 and 4.	RBMS1 LYG2 ACVR2A FREM3 PRKRA PNPT1 TNNI3K TBR1 PSD4	1.51e-04	442	152	9	15815621
Pubmed	Glial ankyrins facilitate paranodal axoglial junction assembly.	ANK2 ANK3	1.88e-04	5	152	2	25362471
Pubmed	Genetic analyses of celiac disease in a Spanish population confirm association with CELIAC3 but not with CELIAC4.	MYO9B LTA	1.88e-04	5	152	2	17767555
Pubmed	Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping.	ERVK-6 ERVK-7	1.88e-04	5	152	2	11401426
Pubmed	Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9.	ACVR2A GDF9	1.88e-04	5	152	2	12135884
Pubmed	Neuroligins and neurexins link synaptic function to cognitive disease.	NLGN4Y NLGN4X	1.88e-04	5	152	2	18923512
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 ERVK-8 USP17L3 USP17L8	8.97e-07	154	152	7	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	1.37e-04	234	152	6	chr8p23
GeneFamily	Ankyrin repeat domain containing	TANC2 ANKRD31 ANK2 ANK3 BCORL1 ANKRD50 KANK1 ANKRD34B ANKRD12	7.85e-06	242	100	9	403
GeneFamily	PRAME family	PRAMEF25 PRAMEF9 PRAMEF15 PRAMEF27	8.60e-06	24	100	4	686
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.49e-06	86	142	6	MM1312
ToppCell	PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MYO1G GBP2 ITGAL STAP1 CD6 LTA ARHGAP45	3.32e-06	194	144	7	69f7bedf6f0be338e4317c22125e727fb82000fc
ToppCell	15-Airway-Immune-Hematopoietic,_T_Cells\|Airway / Age, Tissue, Lineage and Cell class	MYO1G GBP2 ITGAL STAP1 CD6 LTA ARHGAP45	3.43e-06	195	144	7	ec392fc8bd2c0f1e3a79f2e401608fd6ba8d339c
ToppCell	Neuron\|World / Primary Cells by Cluster	ANK2 ANK3 NKAIN2 RTN1 ANKRD12 DAAM1 TBR1	3.92e-06	199	144	7	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	ANK2 ANK3 NKAIN2 RTN1 ANKRD12 DAAM1 TBR1	3.92e-06	199	144	7	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	EBF3 RBMS1 MC4R CLSTN2 FREM3 HHIP	1.10e-05	154	144	6	df1b58a20af73fa79c6c069c0117a9ffd85b476f
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G KBTBD8 ITGAL STAP1 CD6 ARHGAP45	1.10e-05	154	144	6	ee03b386d28a524084eaf1c0091f7389daa34250
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G KBTBD8 ITGAL STAP1 CD6 ARHGAP45	1.10e-05	154	144	6	3fa6f77ad2c30ec24b9b904e2732ec5b419dff5b
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G ITGAL CD6 LTA ARHGAP45 PSD4	1.27e-05	158	144	6	b1b1e50ddd231dcd10cc8e6bb68b2a5e0bb1450a
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HNF1A FREM3 TBX18 HHIP KANK1 CDON	2.13e-05	173	144	6	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G GMIP ITGAL CD6 ARHGAP45 PSD4	2.20e-05	174	144	6	ecee7e012ccd7876fb9df8aa939f8eb05b0c2b13
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO1G GMIP ITGAL CD6 ARHGAP45 PSD4	2.20e-05	174	144	6	693fc31bed0f560644e419fa70ef09f863425416
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HNF1A FREM3 TBX18 HHIP KANK1 CDON	2.20e-05	174	144	6	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SGCB CLSTN2 ARHGEF17 PREX2 NLGN4X IL1R1	2.58e-05	179	144	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1G GBP2 TSHR LTA ARHGAP45 NPIPA2	2.92e-05	183	144	6	450c30d2e389fcb17825394c27f9ccc4f33022e3
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NLGN4Y GRIK4 NKAIN2 PREX2 TMEM132C SCN7A	3.50e-05	189	144	6	203c80030df08ae112f9ae4043709f455d87ce89
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	7.86e-08	46	139	6	DOID:5426 (implicated_via_orthology)
Disease	interleukin-1 receptor-like 2 measurement	HNF1A IL1RL2 IL1R1	1.02e-07	3	139	3	EFO_0801714
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 USP17L8	9.21e-07	69	139	6	DOID:1682 (implicated_via_orthology)
Disease	systolic blood pressure, self reported educational attainment	ANKRD34B CADPS CDON	1.20e-05	10	139	3	EFO_0004784, EFO_0006335
Disease	hepatocellular adenoma (implicated_via_orthology)	HNF1A PTPN11	6.59e-05	3	139	2	DOID:0050868 (implicated_via_orthology)
Disease	TYPE 1 DIABETES MELLITUS	HNF1A ITPR3	1.31e-04	4	139	2	222100
Disease	Diabetes mellitus type 1	HNF1A ITPR3	1.31e-04	4	139	2	cv:C0011854
Disease	insulin resistance	DOCK1 HNF1A ANK2 MTOR	1.76e-04	59	139	4	EFO_0002614
Disease	thyroxine-binding globulin measurement	HNF1A SERPINA7	2.18e-04	5	139	2	EFO_0009172
Disease	Autism spectrum disorder	NLGN4X TBR1	4.56e-04	7	139	2	cv:C1510586
Disease	Alzheimer disease	ANKRD31 ANK3 KBTBD8 NKAIN2 DMXL1 ADAMTS20 MAPK7 ARHGAP45 CDON	5.06e-04	485	139	9	MONDO_0004975
Disease	common bile duct neoplasm (is_marker_for)	MTAP FSCN1	6.06e-04	8	139	2	DOID:4608 (is_marker_for)
Disease	body mass index, age at assessment	MC4R TNNI3K	6.06e-04	8	139	2	EFO_0004340, EFO_0008007
Disease	amyotrophic lateral sclerosis	DOCK1 RBMS1 B4GALT6 PNPT1 SCN7A	6.34e-04	145	139	5	MONDO_0004976
Disease	response to anticonvulsant	ANK2 CLSTN2 PREX2 ADAMTS20	7.11e-04	85	139	4	GO_0036277
Disease	type 1 diabetes mellitus (is_implicated_in)	HNF1A ITPR3 LTA IL1R1	7.11e-04	85	139	4	DOID:9744 (is_implicated_in)
Disease	intraocular pressure measurement	KBTBD8 DRAM2 GRIK4 PNPT1 ELMO3 MTOR ADAMTS20 LSM4 NUP160	7.14e-04	509	139	9	EFO_0004695
Disease	interleukin 1 receptor-like 2 measurement	IL1RL2 IL1R1	7.76e-04	9	139	2	EFO_0008169
Disease	interleukin-1 receptor type 1 measurement	IL1RL2 IL1R1	7.76e-04	9	139	2	EFO_0020487
Disease	autism spectrum disorder (implicated_via_orthology)	TCF20 NLGN4Y ITPR3 NLGN4X TBR1	7.84e-04	152	139	5	DOID:0060041 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	TANC2 ANK2 PTPN11 TBR1	9.95e-04	93	139	4	C1535926
Disease	interleukin 1 receptor-like 1 measurement	IL1RL2 IL1R1	1.18e-03	11	139	2	EFO_0008168
Disease	serum ST2 measurement	IL1RL2 IL1R1	1.18e-03	11	139	2	EFO_0005416
Disease	platelet-to-lymphocyte ratio	MYO1G RBMS1 ITGAL ITPR3 LTA ARHGAP45 NUP160	1.72e-03	363	139	7	EFO_0008446
Disease	neutrophil-to-lymphocyte ratio	RBMS1 AK9 PTPN11 LTA ARHGAP45	1.87e-03	185	139	5	EFO_0008447
Disease	interleukin 18 receptor 1 measurement	IL1RL2 IL1R1	2.22e-03	15	139	2	EFO_0008178
Disease	third ventricle volume measurement	ANK3 NKAIN2	2.22e-03	15	139	2	EFO_0010335
Disease	nervousness	MC4R NUP160	2.53e-03	16	139	2	NCIT_C74532
Disease	Congenital Myasthenic Syndromes, Postsynaptic	AK9 SYT2	2.86e-03	17	139	2	C0751883
Disease	response to opioid	IPO8 NHLRC2 TMEM132C	3.02e-03	61	139	3	EFO_0008541
Disease	alpha synuclein measurement	COG2 PNPT1	3.21e-03	18	139	2	EFO_0009323
Disease	aspartate aminotransferase measurement	ANKRD31 HNF1A TBC1D9B MYH7B NHLRC2 AGBL4 PTPN11 MTOR ENTPD5 ARHGAP45 NUP160	3.76e-03	904	139	11	EFO_0004736
Disease	bone density, lean body mass	MC4R MEPE	4.36e-03	21	139	2	EFO_0003923, EFO_0004995
Disease	ectonucleoside triphosphate diphosphohydrolase 5 measurement	HNF1A ENTPD5	4.36e-03	21	139	2	EFO_0008115

Protein segments in the cluster

Peptide	Gene	Start	Entry
LVQKFHVQYLGMLPV	APBB2	586	Q92870
NVLYGPLHTKQAVSM	ALDH7A1	366	P49419
LPQKLQEAGYSTHMV	ARSI	131	Q5FYB1
YSLPGMKHENILQFI	ACVR2A	236	P27037
KPKNQVLATYMSHEL	BCORL1	981	Q5H9F3
KSHVPQKYRQIFSVM	CFAP46	206	Q8IYW2
KKRNGIMTNPNYHLQ	ANKRD50	1356	Q9ULJ7
QSTQPEMHKYGQLVK	ANKRD12	1701	Q6UB98
GIKYHFNPSQSILVM	CLSTN2	556	Q9H4D0
VGLSIKEAMTYHPNQ	C1GALT1C1	251	Q96EU7
PDIQSNKVYVMHTLA	DMXL1	2221	Q9Y485
GKTTRQVLCMNYHQP	ADAMTS20	1226	P59510
PQKIHQMAASYVQVT	AFF4	1086	Q9UHB7
TQKLTPNLQYIVMHS	CHM	326	P24386
NILGQKVSMHYSDPK	RBM10	196	P98175
HGRQHTIMPSKVNYQ	MTAP	61	Q13126
YLQAKQSLVPAHPMA	RBMS1	21	P29558
VKYGSVIQLLHMKSN	ITPR3	116	Q14573
VTKQYMLNLHSGEVP	ARHGEF17	1006	Q96PE2
PLIVACHYGNVKMVN	ANK2	731	Q01484
LPCGKHTTKQYLNMP	ANKRD34B	156	A5PLL1
IKGKYALPVMVNHQH	CD6	426	P30203
KGLYQITPLHDAVMN	ANKRD31	551	Q8N7Z5
VQAMYRATGQSHKPV	CADPS	616	Q9ULU8
VTMLYINCKVNGHPL	DDI1	241	Q8WTU0
LFPGKNYVHQLQLIM	MAPK7	261	Q13164
RIHVYTFVQKMPGQL	ENTPD5	61	O75356
MHQIISKYPLLNTVE	ARHGAP45	161	Q92619
VLNIIPASMNYAKAH	MEPE	176	Q9NQ76
PMLQHISKNKDTGTY	MYL3	116	P08590
IPLGHMLTQKIAYQI	LRRK1	1356	Q38SD2
GKVSIQQQSHMPLQY	GMIP	136	Q9P107
KSQNPEHYVQVLKRM	EDRF1	826	Q3B7T1
LRQGYQEMTKVHTIP	MYH7B	56	A7E2Y1
MNPIIYSVKTQQIHT	OR51V1	296	Q9H2C8
AQHLYQSILPDMVKI	PARG	586	Q86W56
ILSYQMQPKIHGKQV	DRAM2	141	Q6UX65
QGPQKTSHLQLQPMY	NKAIN2	191	Q5VXU1
KIQTSTPFHYLGMQI	HERVK_113	231	P63132
TPFHYLGMQIENRKI	HERVK_113	236	P63132
FTPYLGHMRNLQKLV	PRAMEF15	226	P0DUQ1
HQNKAGYTPIMLAAL	KANK1	1191	Q14678
NPMKLIQSYADQHKI	LRRC74A	411	Q0VAA2
AKMVKSYLQQHNIPQ	HNF1A	116	P20823
AHYEQQMGQKVQLPT	GBP2	331	P32456
KLVALHKQVLMGPYN	ACBD3	111	Q9H3P7
HYKKNPMVETLGTVL	PTPN11	196	Q06124
PYLTAETLKNRMGHQ	NPIPA2	251	E9PIF3
HNKIYAIPIEIMQGT	HK1	556	P19367
KIQTSTPFHYLGMQI	ERVK-7	231	P63135
TPFHYLGMQIENRKI	ERVK-7	236	P63135
KIQTSTPFHYLGMQI	ERVK-6	231	Q9BXR3
TPFHYLGMQIENRKI	ERVK-6	236	Q9BXR3
NIKSAVLRYNITHPM	NHLRC2	131	Q8NBF2
KYMISHLDPQNSIGV	KBTBD8	141	Q8NFY9
MKLTEPHQVYVQILQ	ORC1	571	Q13415
KIQTSTPFHYLGMQI	ERVK-18	231	Q9QC07
TPFHYLGMQIENRKI	ERVK-18	236	Q9QC07
VMPESIQYIKQKHGA	IL1RL2	496	Q9HB29
EQNSKKPVMVYIHGG	NLGN4Y	161	Q8NFZ3
HCLQMPYKRSGNTVQ	DAAM1	386	Q9Y4D1
HPVTLNVKAEGYTMN	HYDIN	4176	Q4G0P3
YNLGQHKIKFIPEMV	DOCK1	1071	Q14185
IAMHPQVNIYSVTRK	FSCN1	136	Q16658
NVKTIGHMIRLYTNK	B4GALT6	56	Q9UBX8
IGHLQPETSYDIKMQ	CDON	891	Q4KMG0
PTLHGVKQLIVQMYN	AGBL4	301	Q5VU57
GYTPLHIAAKKNQMD	ANK3	631	Q12955
QFIYKNIIHSAAPMG	ELMO3	261	Q96BJ8
KIHPMAYQLQLQAAS	CSNK2B	191	P67870
LSPHTDYQLKAVVQM	MARF1	826	Q9Y4F3
LKFGLMQLDKQTYHP	LYG2	121	Q86SG7
IVAIAKNKNLHSPMY	MC4R	66	P32245
QNHPMLVELKNGETY	LSM4	11	Q9Y4Z0
YIGTQHPQHKAAVML	DHDH	71	Q9UQ10
SPVHTMVQNIIYEKL	GDF9	396	O60383
LSTKYLTMKIQNHPI	CCDC168	6091	Q8NDH2
ESHPNGLQVMYNKLL	COG2	266	Q14746
GLQVMYNKLLEFVPH	COG2	271	Q14746
YGMPHNNQEIILKRA	EBF3	391	Q9H4W6
TTILENPYLMLKGNH	GRIK4	421	Q16099
SPIYMVKTHLQAQAA	SLC25A35	121	Q3KQZ1
HQKYMVPLQASAQEK	SLC22A6	546	Q4U2R8
QLIYPVTNFQKHMIG	IL1R1	326	P14778
DQNSKKPVMVYIHGG	NLGN4X	161	Q8N0W4
ISNQIQAKEYMKPHV	IPO8	526	O15397
PYKHKVNIGMIDQSR	MTOR	896	P42345
ITQVPMHGKILYNGS	FREM3	1576	P0C091
GNHQMVIQKKVLYPA	RTKN2	476	Q8IZC4
SMFTLPVVYVKHQAQ	RTN1	731	Q16799
SDPYVKIHLMQNGKR	SYT2	306	Q8N9I0
GVLAKIVNYMKTRHQ	GTF2E2	76	P29084
PGYVVTPHTMNLLKQ	QARS1	241	P47897
NHIVQYTLNMKLKPL	AK9	1301	Q5TCS8
VIDGYPVTKHQMNLL	AK9	1496	Q5TCS8
NGQMVVLQSLHKYQP	TBR1	321	Q16650
NTESYLKNVALKHMP	GINS4	136	Q9BRT9
HMLQANKTYGCVPVA	SPAG7	181	O75391
KYRHKQVPLEGQASM	TMEM132C	951	Q8N3T6
PTYKQGILARKMHQD	PSD4	776	Q8NDX1
FTPYLGHMRNLQKLV	PRAMEF25	226	A6NGN4
NIGIITHYKAQKTMI	SETX	2341	Q7Z333
NKVHIKRPTTGLLMY	ST8SIA2	286	Q92186
VLPAPKLKMTNNHIY	SHCBP1L	571	Q9BZQ2
MGIIDKTARTQQYPH	TANC2	1846	Q9HCD6
FTPYLGHMRNLQKLV	PRAMEF27	226	A3QJZ7
SLLPQNYCKGIMHLK	WDR17	771	Q8IZU2
TTKPDYAGHQLQQIM	SNUPN	296	O95149
IHQVKHMYQVRIQPS	ITGAL	946	P20701
KEHKPYQTMLVLGSQ	SNAPC3	196	Q92966
KQVSDMGVIHPLYKS	SGCB	111	Q16585
VKLYPNMTAVLLHNT	PNPT1	696	Q8TCS8
NPHTNMVCLLKKGYL	NUP160	551	Q12769
MTQTHNGKLYKIVDP	HHIP	571	Q96QV1
QPADVIKTHMQLYPL	SLC25A38	236	Q96DW6
KLHIPGQMFISNNYI	TBC1D9B	316	Q66K14
LQSESNKKPIHMYIN	CLPP	106	Q16740
KIQTSTPFHYLGMQI	ERVK-25	231	P63136
TPFHYLGMQIENRKI	ERVK-25	236	P63136
TKMHEIYKGNITPQL	UHRF1BP1L	666	A0JNW5
PNALVIHQSKYKCGM	USP17L3	461	A6NCW0
GKMQNSDCPKIHYVI	RNASE13	61	Q5GAN3
QYPFHVPLLSSQKMV	LTA	141	P01374
NLVVHQRMHTGEKPY	ZNF197	916	O14709
PVKNYQAHQSRVTMI	WDFY2	106	Q96P53
QLIVHQRSHTGMKPY	ZNF268	486	Q14587
PNVLVIHQSKYKCGM	USP17L4	461	A6NCW7
QTVSGHLYKVNVPIM	GTF2A1L	126	Q9UNN4
AMRVKISGLDPHQQY	TBX18	171	O95935
FTPYLGHMRNLQKLV	PRAMEF9	226	P0DUQ2
IPRIKHYKVMSVGQN	STAP1	221	Q9ULZ2
DLKPNTIMVLVNYIH	SERPINA7	191	P05543
KIQTSTPFHYLGMQI	ERVK-10	231	P10266
TPFHYLGMQIENRKI	ERVK-10	236	P10266
KIQTSTPFHYLGMQI	ERVK-8	231	P63133
TPFHYLGMQIENRKI	ERVK-8	236	P63133
KVIQHQSMHSGLKPY	ZNF840P	221	A6NDX5
KIQTSTPFHYLGMQI	ERVK-11	231	Q9UQG0
TPFHYLGMQIENRKI	ERVK-11	236	Q9UQG0
HLSSLPTQMDYKGQK	SPCS1	71	Q9Y6A9
SSEQGKLSPMVYIQH	PREX2	976	Q70Z35
PNALVIHQSKYKCGM	USP17L1	461	Q7RTZ2
QHVMQYTNAATKLPL	TCF20	326	Q9UGU0
IQVLHEYGMKTKNIP	PRKRA	36	O75569
HVLKLPYQGNATMLV	SERPINA10	286	Q9UK55
QLIQHQIIHTGMKPY	ZNF404	201	Q494X3
PNVLVIHQSKYKCGM	USP17L7	461	P0C7H9
PNVLVIHQSKYKCGM	USP17L8	461	P0C7I0
HYPMSKQTNTLLNIG	SCN7A	526	Q01118
QMKIISENVPSYKTH	ZNF529	141	Q6P280
LQLNIHTGVKPCKYM	ZNF529	216	Q6P280
PSYKENVMKLSIIQH	UGT2B28	436	Q9BY64
GITQNALDYMKKHIP	UBR4	4686	Q5T4S7
AKGMEYLHNLTQPII	TNNI3K	571	Q59H18
KEVQQLTVKHGGQYM	TOPBP1	216	Q92547
LPKYSHNSLMVQAIK	WDR7	666	Q9Y4E6
PNVLVIHQSKYKCGM	USP17L2	461	Q6R6M4
PGQVQVHKMKAVYLA	TCIRG1	291	Q13488
TAHMPSKVKAQLYAQ	TMEM260	606	Q9NX78
IKPGEHMICQQYISK	TTLL13	221	A6NNM8
HLTPKKQGQISEEYM	TSHR	746	P16473
NLMQHQRIHTGEKPY	ZNF787	136	Q6DD87
ASKHIMQYIAAVTNP	MYO1G	111	B0I1T2
LPHSKTKNVINYQMR	MYO3A	881	Q8NEV4
KMYENQQLGKLEPHV	MYO9B	201	Q13459
NIKTMYSVPNGKIHV	MYO9B	1546	Q13459